Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.2M Buy
154,824
+74,443
+93% +$8.59M 0.11% 175
2025
Q4
$8.46M Sell
80,381
-6,825
-8% -$641K 0.06% 256
2025
Q3
$7.32M Buy
87,206
+2,442
+3% +$201K 0.05% 266
2025
Q2
$6.71M Sell
84,764
-720
-0.8% -$57.2K 0.06% 262
2025
Q1
$7.67M Sell
85,484
-53,755
-39% -$5.02M 0.07% 226
2024
Q4
$13.9M Buy
139,239
+55,396
+66% +$5.71M 0.13% 137
2024
Q3
$9.52M Buy
83,843
+10,216
+14% +$1.21M 0.09% 177
2024
Q2
$9.12M Buy
73,627
+5,405
+8% +$696K 0.1% 171
2024
Q1
$9M Buy
68,222
+5,675
+9% +$699K 0.1% 161
2023
Q4
$6.82M Buy
62,547
+6,373
+11% +$662K 0.08% 178
2023
Q3
$5.78M Buy
56,174
+9,205
+20% +$992K 0.08% 181
2023
Q2
$5.42M Buy
46,969
+4,857
+12% +$551K 0.08% 181
2023
Q1
$4.48M Buy
42,112
+11,535
+38% +$1.25M 0.07% 190
2022
Q4
$3.39M Sell
30,577
-10,177
-25% -$1.04M 0.06% 211
2022
Q3
$3.51M Buy
40,754
+2,119
+5% +$189K 0.07% 189
2022
Q2
$3.52M Buy
38,635
+2,511
+7% +$223K 0.07% 182
2022
Q1
$2.96M Buy
36,124
+4,131
+13% +$326K 0.05% 223
2021
Q4
$2.45M Buy
31,993
+1,576
+5% +$126K 0.04% 247
2021
Q3
$2.29M Buy
30,417
+593
+2% +$45.1K 0.04% 247
2021
Q2
$2.32M Buy
29,824
+3,580
+14% +$266K 0.04% 243
2021
Q1
$1.93M Buy
26,244
+7,059
+37% +$521K 0.04% 251
2020
Q4
$1.5M Sell
19,185
-2,211
-10% -$169K 0.03% 265
2020
Q3
$1.69M Buy
21,396
+113
+0.5% +$8.85K 0.04% 234
2020
Q2
$1.57M Buy
21,283
+2,289
+12% +$172K 0.05% 238
2020
Q1
$1.39M Sell
18,994
-1,018
-5% -$80K 0.05% 215
2019
Q4
$1.74M Buy
+20,012
New +$1.64M 0.05% 217

Other funds holding MRK

Equitable Holdings's MRK Position: Q1 2026 in Review

Equitable Holdings increased its Merck (MRK) stake by 93% in Q1 2026, buying an estimated $8.59M and bringing the position to 154,824 shares worth $17.2M. The position accounts for 0.11% of the portfolio, ranked #175.

Equitable Holdings first reported a position in MRK in Q4 2019 and has held it in 26 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Equitable Holdings held 154,824 shares of Merck worth $17.2M as of Q1 2026.
  • Equitable Holdings bought 74,443 Merck shares in Q1 2026, an estimated $8.59M.
  • Merck made up 0.11% of Equitable Holdings's portfolio in Q1 2026, its #175 holding.
  • Equitable Holdings first reported a position in Merck in Q4 2019 and has held it in 26 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.